Can you provide the last earnings date for GALMED PHARMACEUTICALS LTD?
GALMED PHARMACEUTICALS LTD (GLMD) last reported earnings on 3/31/2026.
GALMED PHARMACEUTICALS LTD (GLMD) Earnings History & Surprises
NASDAQ:GLMD • IL0011313900
Current stock price
0.741 USD
-0.04 (-5.63%)
At close:
0.7201 USD
-0.02 (-2.82%)
After Hours:
GLMD Earnings overview
Past quarterly earnings results for GALMED PHARMACEUTICALS LTD (GLMD), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 20, 2026
Last Reported
Most Recent- Release Date
- Mar 31, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.80
- EPS Surprise
- -53.79%
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.80 | -0.52 | -53.79% | - | - | - | ||
| Q3 2025 | -0.33 | -0.55 | 40.09% | - | - | - | ||
| Q2 2025 | -0.63 | -0.85 | 25.58% | - | - | - | ||
| Q1 2025 | -0.62 | -0.91 | 31.70% | - | - | - | ||
| Q4 2024 | - | - | - | - | ||||
| Q3 2024 | - | - | - | - | ||||
| Q2 2024 | - | - | - | - | ||||
| Q1 2024 | - | - | - | - | ||||
| Q4 2023 | -11.76 | -3.92 | -200.25% | 34.67% | - | - | ||
| Q3 2023 | -2.88 | -3.30 | 12.85% | 92.38% | - | - | ||
| Q2 2023 | -11.40 | -4.16 | -173.93% | 57.78% | - | - | ||
| Q1 2023 | -13.08 | -18.36 | 28.76% | 69.72% | - | - | ||
| Q4 2022 | -18.00 | -25.70 | 29.97% | 66.67% | - | - | ||
| Q3 2022 | -37.80 | -30.29 | -24.78% | 32.26% | - | - | ||
| Q2 2022 | -27.00 | -43.33 | 37.69% | 54.55% | - | - | ||
| Q1 2022 | -43.20 | -58.75 | 26.47% | 36.84% | - | - | ||
| Q4 2021 | -54.00 | -55.54 | 2.77% | 37.50% | - | - | ||
| Q3 2021 | -55.80 | -65.73 | 15.11% | 3.13% | - | - | ||
| Q2 2021 | -59.40 | -70.14 | 15.31% | -26.92% | - | - | ||
| Q1 2021 | -68.40 | -70.69 | 3.23% | -31.03% | - | - | ||
| Q4 2020 | -86.40 | -66.83 | -29.28% | - | - | - | ||
| Q3 2020 | -57.60 | -55.08 | -4.58% | - | - | - | ||
| Q2 2020 | -46.80 | -58.49 | 19.99% | - | - | - | ||
| Q1 2020 | -52.20 | -67.24 | 22.37% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
Related analysis
GALMED PHARMACEUTICALS LTD / GLMD Earnings FAQ
Did GALMED PHARMACEUTICALS LTD (GLMD) beat earnings estimates last quarter?
GALMED PHARMACEUTICALS LTD (GLMD) missed EPS estimates and missed revenue estimates in the most recent quarter.